| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |